# Muthiah Vaduganathan

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/muthiah-vaduganathan/

## Facts

| Field | Value |
| --- | --- |
| Citations | 91,463 |
| Field | Heart Failure Treatment and Management |
| h-index | 103 |
| i10-index | 548 |
| Last Known Institution | Brigham and Women's Hospital |
| OpenAlex ID | https://openalex.org/A5061881316 |
| ORCID iD | 0000-0003-0885-1953 |
| Works | 1,171 |

## Researcher papers

Showing 12 of 28.

- [Dapagliflozin in Heart Failure with Mildly Reduced or Preserved Ejection Fraction](https://scholariq.org/papers/dapagliflozin-in-heart-failure-with-mildly-reduced-or-preserved-ejection/)
- [Renin–Angiotensin–Aldosterone System Inhibitors in Patients with Covid-19](https://scholariq.org/papers/renin-angiotensin-aldosterone-system-inhibitors-in-patients-with-covid-19/)
- [The Global Burden of Cardiovascular Diseases and Risk](https://scholariq.org/papers/the-global-burden-of-cardiovascular-diseases-and-risk/)
- [The Global Health and Economic Burden of Hospitalizations for Heart Failure](https://scholariq.org/papers/the-global-health-and-economic-burden-of-hospitalizations-for-heart-failure/)
- [Impact of diabetes on the effects of sodium glucose co-transporter-2 inhibitors on kidney outcomes: collaborative meta-analysis of large placebo-controlled trials](https://scholariq.org/papers/impact-of-diabetes-on-the-effects-of-sodium-glucose-co-transporter-2-inhibitors/)
- [SGLT2 inhibitors in patients with heart failure: a comprehensive meta-analysis of five randomised controlled trials](https://scholariq.org/papers/sglt2-inhibitors-in-patients-with-heart-failure-a-comprehensive-meta-analysis-of/)
- [Finerenone in Heart Failure with Mildly Reduced or Preserved Ejection Fraction](https://scholariq.org/papers/finerenone-in-heart-failure-with-mildly-reduced-or-preserved-ejection-fraction/)
- [Heart Failure Epidemiology and Outcomes Statistics: A Report of the Heart Failure Society of America](https://scholariq.org/papers/heart-failure-epidemiology-and-outcomes-statistics-a-report-of-the-heart-failure/)
- [Estimating lifetime benefits of comprehensive disease-modifying pharmacological therapies in patients with heart failure with reduced ejection fraction: a comparative analysis of three randomised controlled trials](https://scholariq.org/papers/estimating-lifetime-benefits-of-comprehensive-disease-modifying-pharmacological/)
- [Sacubitril/Valsartan Across the Spectrum of Ejection Fraction in Heart Failure](https://scholariq.org/papers/sacubitril-valsartan-across-the-spectrum-of-ejection-fraction-in-heart-failure/)
- [Titration of Medical Therapy for Heart Failure With Reduced Ejection Fraction](https://scholariq.org/papers/titration-of-medical-therapy-for-heart-failure-with-reduced-ejection-fraction/)
- [Fewer Hospitalizations for Acute Cardiovascular Conditions During the COVID-19 Pandemic](https://scholariq.org/papers/fewer-hospitalizations-for-acute-cardiovascular-conditions-during-the-covid-19/)

## Researcher topics

- [Heart Failure Treatment and Management](https://scholariq.org/topics/heart-failure-treatment-and-management/)
- [Cardiovascular Function and Risk Factors](https://scholariq.org/topics/cardiovascular-function-and-risk-factors/)
- [Diabetes Treatment and Management](https://scholariq.org/topics/diabetes-treatment-and-management/)
- [Cardiac pacing and defibrillation studies](https://scholariq.org/topics/cardiac-pacing-and-defibrillation-studies/)
- [Acute Myocardial Infarction Research](https://scholariq.org/topics/acute-myocardial-infarction-research/)

## Researcher university

- [Brigham and Women's Hospital](https://scholariq.org/institutions/brigham-and-women-s-hospital/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.